ANI Pharmaceuticals, Inc. (ANIP)

Nasdaq: ANIP · Pharmaceutical Preparations · Baudette, MN · filing with the SEC since 1999

Grade6.3

◀ Past 6.3● Present 6.6▶ Future 5.8

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 27, 2026	Feb 28, 2025	Feb 29, 2024	Mar 9, 2023	Mar 15, 2022	Mar 11, 2021	Feb 27, 2020	Feb 27, 2019	Feb 27, 2018	Mar 2, 2017
Revenue	883,366	614,376	486,816	316,385	216,136	208,475	206,547	201,576	176,842	128,622
For lenders
Interest and dividend income	12,502	16,026	8,694	461	·	·	·	·	·	·
Cost of revenue	341,310	250,210	181,513	138,785	100,610	87,157	63,154	73,024	79,032	48,780
Research and development	51,664	44,581	34,286	22,318	11,369	16,001	19,806	15,388	9,070	2,906
Selling, general and administrative	317,745	249,636	161,697	124,044	84,294	64,986	55,843	44,063	31,580	27,829
Total costs and expenses	772,273	613,792	439,845	351,668	255,929	224,491	190,196	166,217	148,513	108,543
Operating income	111,093	584	46,971	-35,283	-39,793	-16,016	16,351	35,359	28,329	20,079
Interest expense	32,562	33,628	35,634^r	28,513^r	11,945	9,479	13,468	14,911	11,324	11,294
Interest income (expense), net	-20,060	-17,602	-26,940	-28,052	-11,922	-9,452	-12,966	-14,758	-12,035	-11,327
Other income (expense), net	1,934	-4,033	-159	670	-4,343	-494	-228	-550	55	-74
Income before income taxes	95,791	-22,212	19,872	-62,665	-56,058	-25,962	3,157	20,051	16,349	8,678
Income tax expense	17,454	-3,690	1,093	-14,769	-13,455	-3,414	-2,937	4,557	17,425	4,744
Income from continuing operations	·	·	·	·	·	·	6,094	15,494	-1,076	3,934
Net income including non-controlling interests	78,337	-18,522	18,779	-47,896	-42,603	-22,548	·	·	·	·
Net income	78,337	-18,522	18,779	-47,896	-42,603	-22,548	6,094	15,494	-1,076	3,934
Preferred dividends	1,157	1,625	1,625	1,625	190	·	·	·	·	·
Net income to common shareholders	77,180	-20,147	17,154	-49,521	-42,793	-22,548	6,094^r	15,340	-1,076	3,913
Earnings per share, basic	3.50	-1.04	0.86	-3.05	-3.40	-1.88	0.51	1.31	-0.09	0.34
Earnings per share, diluted	3.32	-1.04	0.85	-3.05	-3.40	-1.88	0.50	1.30	-0.09	0.34
Weighted average shares, basic	20,053	19,318	18,001	16,260	12,596	11,964	11,841	11,677	11,547	11,445
Weighted average shares, diluted	21,228	19,318	18,194	16,260	12,596	11,964	12,040	11,772	11,547	11,573

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-6 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues

Interest and dividend income what its loans and securities earnedus-gaap:InterestAndDividendIncomeOperating

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
us-gaap:CostOfRevenue

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpenseDebt

Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton ANIP · research, not advice